Outcome of childhood acute lymphoblastic leukemia treatment in a single center in Brazil: A survival analysis study
Open Access
- 11 June 2021
- journal article
- research article
- Published by Wiley in Cancer Reports
- Vol. 5 (1) , e1452
Abstract
Background: Acute lymphoblastic leukemia (ALL) is the most common neoplasm in childhood. The probability of current overall survival (OS) is around 90% in developed countries. There are few studies that demonstrate the results in Brazil.Aim: This work aims to analyze the results of children with ALL treated at a single institution in Rio de Janeiro.Methods and results: Retrospective analysis survival study of a cohort of childhood ALL patients treated in Hemorio. Kaplan–Meier and log‐rank methods were used for the analysis of OS and events‐free survival (EFS) and the Cox proportional hazards regression model for multivariate analysis.The probability of OS and EFS at 6 years was 52% and 45%. The probability of OS and EFS in 6 years for patients aged 10‐17 years was 31% and 28% and for the younger was 65% and 55%, respectively (p < .001). A probability of OS and EFS in 6 years for patients with more than 100 000 leukocytes/mm3 at diagnosis was 19% and 16% and those with less than 100 000 were 62% (p = .007) and 55% (p = .008). Those who received less than 10 doses of native Escherichia coli asparaginase had a probability of OS and EFS in 6 years of 27% and 21% and those who received at least 10 doses were 74% and 65% (p < .001).Conclusions: The presence of a high number of adolescents and high‐risk patients, as well as many patients who discontinued the use of asparaginase or any substitute led to a lower probability of OS and EFS in our cohort.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaFrontiers in Oncology, 2014
- Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002Journal of Clinical Oncology, 2014
- Radiotherapy and the Tumor Stroma: The Importance of Dose and FractionationFrontiers in Oncology, 2014
- Acute lymphoblastic leukaemiaThe Lancet, 2013
- Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Blood, 2012
- Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)Blood, 2011
- Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone MarrowJournal of Clinical Oncology, 2009
- Acute lymphoblastic leukaemiaThe Lancet, 2008
- Fatores prognósticos em crianças e adolescentes com Leucemia Linfóide AgudaRevista Brasileira de Saúde Materno Infantil, 2007
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001